At-home DNA tests have become increasingly popular in recent years. But are they actually helpful for detecting cancer risk? In this post, learn about at-home DNA tests for cancer risk and why it’s always best to get genetic screening done through your health care provider.
In this month’s “From the Editor in Chief” column, Dr. Jyoti Patel discusses the importance of the reignited Cancer Moonshot program, including how the initiative has already helped improve cancer care and what the initiative’s new goals mean for the future.
In this “Cancer in My Community” post, Drs. Mastura Md Yusof and Wan Zamaniah Wan Ishak discuss what cancer is like in Malaysia, including the increase in cases in recent years and the measures being taken to reduce cancer throughout the country and improve access to care.
The American Society of Clinical Oncology (ASCO) and the American Cancer Society (ACS) have launched a collaboration to make expert-approved cancer information more easily accessible. Here, learn what this collaboration looks like and where you can find trusted resources from both organizations on ASCO’s Cancer.Net and ACS’s Cancer.org.
In this “Voices on Cancer” post, prostate cancer survivor James E. Williams, Jr., shares how his experience with prostate cancer led him to understand the importance of patient advocacy and inspired him to get involved in bringing awareness to the disease.
In this month’s “From the Editor in Chief” column, Dr. Jyoti Patel discusses how the COVID-19 pandemic has impacted cancer screening and why it’s so important for everyone to keep up with their regular checkups.
Dr. Eleonora Teplinsky discusses how the symptoms of menopause can be similar to those of certain types of cancer, what people approaching or going through menopause should know about these symptoms, and how treatment for menopause can impact cancer risk.
In this webinar, experts discuss new research in gynecologic cancers, advanced melanoma, and cancer in people age 65 or older presented at the 2021 ASCO Annual Meeting.
Read early research highlights just released for the 2021 ASCO Annual Meeting. Topics include immunotherapy for melanoma and non-small cell lung cancer, PSA screening for prostate cancer, HPV vaccination, and Medicaid income eligibility limits.
Lea los puntos destacados de la investigación temprana que acaban de publicar para la reunión anual de la American Society of Clinical Oncology (Sociedad Americana de Oncología Clínica) de 2021. Los temas incluyen la inmunoterapia para el melanoma y el cáncer de pulmón de no microcítico (NSCLC, por sus siglas en inglés), la detección del antígeno prostático específico (PSA, por sus siglas en inglés) para el cáncer de próstata, la vacunación contra el VPH y los límites de elegibilidad de los ingresos de Medicaid.
